reports
New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlig...
New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population iRhythm Technologies presented new data during the joint Asia Pacific Heart Rhythm Society (APHRS) and Japan Heart Rhythm Society (JHRS) scientific sessions.Large-scale analysis of more than 400,000 patients1 supports the consistency and generalizability of Zio long-term ECG monitoring (LTCM) performance across populations; median wear and analyzable time among patients identified as Asian (3.4% of the cohort) were comparable to tho...
第18回アジア太平洋不整脈学会学術大会（APHRS2025）で発表された新たなデータにより アジア人集団におけるiRhythm社のZio長期...
第18回アジア太平洋不整脈学会学術大会（APHRS2025）で発表された新たなデータにより アジア人集団におけるiRhythm社のZio長期連続モニタリングの性能が明らかに iRhythm Technologies, Inc.は、アジア太平洋不整脈学会学術大会（APHRS2025）と第71回日本不整脈心電学会学術大会（JHRS2025）の合同学術集会において新しいデータを発表しました。40万人を超える患者を対象とした大規模解析 1 により、長期間の心電図（ECG）モニタリングの性能の一貫性と一般化可能性が裏付けられました。アジア人患者（コホートの3.4%）における中央値の装着時間および解析可能時間は非アジア人患者と同等であり、この結果は既発表のCAMELOT研究2 およびAVALON研究3 で報告されたZio LTCMの性能と一致していました。 サンフランシスコ, Nov. 21, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC) は2025年11月12日から15日まで日本・横浜で開催された第18回アジア太平洋不整脈学会（APHRS）／第71回日本不整脈心電学会学術大会（JHRS2025）合同学術集会において、口頭発表セッションで新たなデータを発表したと明らかにしました。 河田 宏医師の主導のもと、研究チームは米国の大規模患者コホートを対...
iRhythm Technologies Announces Publication of Large-Scale Study in Hea...
iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025 Real-world data across more than 1 million patients published in Heart Rhythm show that 24–48-hour monitoring can miss actionable arrhythmias and highlights the value of iRhythm’s Zio® long-term continuous monitoring (LTCM)– even in patients with frequent (i.e., daily) symptoms1Data from more than 742,000 patients presented at the American Heart Association (AHA) Scientific Sessions 2025 confirm that at-home self-application and activation of Zio 14-day patc...
iRhythm Technologies to Participate in Upcoming Investor Conferences
iRhythm Technologies to Participate in Upcoming Investor Conferences SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences. Wolfe Research 2025 Healthcare Conference on Tuesday, November 18, 2025, at 9:20 a.m. Eastern Time (6:20 a.m. Pacific Time)Jefferies 2025 Global Healthcare Conference on Thursday, November 20, 2025, at 9:30 a.m. Greenwich Mean Time (1:30...
Irhythm Technologies Inc: 1 director
A director at Irhythm Technologies Inc sold 8,000 shares at 207.440USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
iRhythm Technologies Announces Third Quarter 2025 Financial Results
iRhythm Technologies Announces Third Quarter 2025 Financial Results SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended September 30, 2025. Third Quarter 2025 Financial Highlights Revenue of $192.9 million, a 30.7% increase compared to third quarter 2024Gross margin of 71.1%, a 230-basis point increase compared to third quarter 2024Unrestricted cash, cash equivalents, and...
iRhythm Technologies to Report Third Quarter 2025 Financial Results on...
iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025 SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third quarter 2025 after the close of trading on Thursday, October 30, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the con...
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial ...
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA).AMALFI tested whether home-based, self-applied use of iRhythm’s Zio long-term continuous monitoring (LTCM) device and service could improve diagnosis of atrial fibrillation (AFib) in 5040 participants in the United ...
iRhythm Technologies to Participate in Upcoming Investor Conferences
iRhythm Technologies to Participate in Upcoming Investor Conferences SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences. Wells Fargo 2025 Healthcare Conference on Wednesday, September 3, 2025, at 12:45 p.m. Eastern Time (9:45 a.m. Pacific Time)Morgan Stanley Global Healthcare Conference 2025 on Tuesday, September 9, 2025, at 2:35 p.m. Eastern Time (11:35 a...
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm...
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, cardiovascular events, and total health care costs.Findings in a younger, commercially insured population build on data from the Medicare fee-for-service, population-based CAMELOT study, confirming the Zio LTCM service’s value across patient populations and payer segments. SAN FRANCISCO, Aug....
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution f...
iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions Partnership aims to utilize predictive AI to help identify arrhythmias earlier in patient populations with an elevated risk for arrhythmias to enable timely care for millions who remain undiagnosedCommercial offering from this collaboration designed to support scalable population health and value-based care strategies SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a digital health leader focused on creating trusted solut...
iRhythm Technologies Announces Second Quarter 2025 Financial Results
iRhythm Technologies Announces Second Quarter 2025 Financial Results SAN FRANCISCO, July 31, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended June 30, 2025. Second Quarter 2025 Financial Highlights Revenue of $186.7 million, a 26.1% increase compared to second quarter 2024Gross margin of 71.2%, a 130-basis point increase compared to second quarter 2024Unrestricted cash, cash equivalents, and marketable securit...
iRhythm Technologies to Report Second Quarter 2025 Financial Results o...
iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025 SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter 2025 after the close of trading on Thursday, July 31, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the confere...
iRhythm Technologies Announces Board Member Retirements and New Direct...
iRhythm Technologies Announces Board Member Retirements and New Director Appointments SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retirement of two long-serving board members, Mark Rubash and Ralph Snyderman, M.D., effective July 7, 2025. Concurrently, Karen McGinnis and Kevin O’Boyle have accepted appointments to the board of directors. Mark Rubash has served on the board since 2016, prior to the company’s initial public offerin...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
TWI TITAN INTERNATIONAL INC.
TTMI TTM TECHNOLOGIES INC.
TPH TRI POINTE HOMES INC.
TDOC TELADOC HEALTH INC.
NTRS NORTHERN TRUST CORPORATION
LINC LINCOLN EDUCATIONAL SERVICES
PLNT PLANET FITNESS INC. CLASS A
GOGO GOGO INC.
FHN FIRST HORIZON CORPORATION
EXEL EXELIXIS INC.
EVH EVOLENT HEALTH INC CLASS A
DY DYCOM INDUSTRIES INC.
CRM SALESFORCE.COM INC.
BZH BEAZER HOMES USA INC.
APEI AMERICAN PUBLIC EDUCATION
CIVB CIVISTA BANCSHARES
ALV ALLIANZ SE
CW CURTISS-WRIGHT CORPORATION
PARR PAR PACIFIC HOLDINGS INC
TAYD TAYLOR DEVICES INC.
VVV VALVOLINE INC.
IRTC IRHYTHM TECHNOLOGIES INC.
LAUR LAUREATE EDUCATION INC. CLASS A
MCB METROPOLITAN BANK HOLDING
BKNG BOOKING HOLDINGS INC.
HOV HOVNANIAN ENTERPRISES INC. CLASS A
HWM HOWMET AEROSPACE INC.
TSO TESORO RESOURCES
FWONA LIBERTY FORMULA ONE
New Data Presented at ADA 2025 Highlights Burden and Risk Associations...
New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease Retrospective real-world analyses of patients with type 2 diabetes—some of whom also had chronic kidney disease—demonstrate cardiac arrhythmias present frequent and early, often preceding major cardiovascular events (MACE) SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC) announced the results from two large-scale real-world studies presented at the American Diabetes Association’s 85th Scientific Sessions (ADA 2025). The ...
iRhythm Technologies to Participate in Upcoming Investor Conferences
iRhythm Technologies to Participate in Upcoming Investor Conferences SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences. William Blair 45th Annual Growth Stock Conference on Wednesday, June 4, 2025, at 2:00 p.m. Central Time (12:00 p.m. Pacific Time)Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 2:40 p.m. Eastern Time (...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
TITN TITAN MACHINERY
RCKY ROCKY BRANDS
LNDC LANDEC CORP.
EXAS EXACT SCIENCES CORPORATION
CRK COMSTOCK RESOURCES INC.
BEN FRANKLIN RESOURCES INC.
ATI ALLEGHENY TECHNOLOGIES INCORPORATED
BJRI BJ'S RESTAURANTS INC.
AVH AVITA MEDICAL CDI
ATEC ALPHATEC HOLDINGS INC.
WHG WESTWOOD HOLDINGS GROUP INC.
FLGT FULGENT GENETICS
IRTC IRHYTHM TECHNOLOGIES INC.
LAUR LAUREATE EDUCATION INC. CLASS A
ATGE ADTALEM GLOBAL EDUCATION INC.
OCBI ORANGE COUNTY BANCORP
ATOM ATOMERA
FULC FULCRUM THERAPEUTICS
IESC IES HOLDINGS INC.
ADPT ADAPTIVE BIOTECHNOLOGIES
PRDO PERDOCEO EDUCATION CORP
HIMS HIMS AND HERS HEALTH INC (A)
ACHR ARCHER AVIATION INC
ASTS AST SPACEMOBILE INC
RGTI RIGETTI COMPUTING INC
SKWD SKYWARD SPECIALTY INS GROUP INC
ASPI ASP ISOTOPES INC
BTSG BRIGHTSPRING HEALTH SERVICES INC.
DAVE DAVE INC
ASMB ASSEMBLY BIOSCIENCES INC
AEVA AEVA TECHNOLOGIES INC.
BKTI BK TECHNOLOGIES CORP
ALMU AELUMA INC
ACOG ALPHA COGNITION INC
iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan...
iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection iRhythm Zio® Long-Term Continuous Monitoring (LTCM) system — commercially introduced in Japan as the Zio® ECG Recording and Analysis System — brings AI-powered, continuous, uninterrupted ECG monitoring for up to 14 days to JapanLaunch is timely amid a growing demand for early, accurate detection of arrhythmias in Japan, the second largest ambulatory cardiac monitoring market in the world, where the prevalence is expected to rise alon...
iRhythm Technologies Announces First Quarter 2025 Financial Results
iRhythm Technologies Announces First Quarter 2025 Financial Results SAN FRANCISCO, May 01, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2025. First Quarter 2025 Financial Highlights Revenue of $158.7 million, a 20.3% increase compared to first quarter 2024Gross margin of 68.8%, a 250-basis point increase compared to first quarter 2024Unrestricted cash, cash equivalents, and marketable securities of $520....
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.